Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis.
在接受透析的日本患者中,較低的副甲狀腺激素水平與降低骨折風險相關。
Kidney Int Rep 2024-10-21
Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients.
血清磷與血液透析患者骨折風險增加相關。
Nephrol Dial Transplant 2024-03-29
Relationship between biochemical parameters of mineral bone disease and static bone histomorphometry in chronic kidney disease patients on hemodialysis: An Indian cross-section study.
慢性腎臟病血液透析患者的礦物質骨疾病生化參數與靜態骨組織形態學之間的關係:一項印度橫斷面研究。
Nefrologia (Engl Ed) 2024-02-23
Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS.
鹼性磷酸酶和甲狀旁腺激素水平:國際變異及其與DOPPS中臨床結果的關聯。
Kidney Int Rep 2024-05-20
The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients.
Etelcalcetide治療降低甲狀旁腺素對血液透析患者鈣化傾向和鈣蛋白粒子的影響。
Clin Kidney J 2024-06-26
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients.
血清鎂水平較低與透析患者骨折及血管鈣化風險增加相關。
Clin Kidney J 2025-02-26